PMID: 2566179Jan 1, 1989Paper

The polymorphic oxidation of beta-adrenoceptor antagonists

Pharmacology & Therapeutics
M S Lennard

Abstract

No abstract listed.

References

Nov 1, 1976·Progress in Cardiovascular Diseases·M E ConollyC T Dollery
Jan 1, 1976·Clinical Pharmacokinetics·G Johnsson, C G Regàrdh
Dec 15, 1979·British Medical Journal·R Stone
Sep 17, 1977·Lancet·A MahgoubR L Smith
Oct 1, 1977·Lancet·G T TuckerA J Smith
Oct 1, 1975·Clinical Pharmacology and Therapeutics·G R Wilkinson, D G Shand
Mar 1, 1985·British Journal of Clinical Pharmacology·R V LewisH F Woods
Jan 1, 1985·European Journal of Clinical Pharmacology·P DayerT Leemann
Oct 1, 1985·Clinical Pharmacology and Therapeutics·J C McGourtyJ W Ward
Dec 1, 1985·British Journal of Clinical Pharmacology·J C McGourtyH F Woods
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M S LennardH F Woods
Sep 1, 1986·Medical Toxicology·R V Lewis, D G McDevitt
Jan 1, 1988·Biochemical Pharmacology·T WalleT E Gaffney
Aug 15, 1986·Biochemical Pharmacology·M S LennardH F Woods
Apr 1, 1986·Clinical Biochemistry·W Kalow
Jun 26, 1986·The New England Journal of Medicine·S H CroogG H Williams
Jan 1, 1987·European Journal of Clinical Pharmacology·W Kalow
Aug 1, 1987·British Journal of Clinical Pharmacology·F WagnerH Roskamm
Jan 1, 1986·European Journal of Clinical Pharmacology·T LeemannU A Meyer
May 1, 1986·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M EichelbaumC Zekorn
Oct 1, 1986·Clinical Pharmacology and Therapeutics·A O IyunH F Woods
Oct 1, 1986·Chemico-biological Interactions·J H Riviere, D J Back
Nov 1, 1986·British Journal of Clinical Pharmacology·P R JacksonH F Woods
Jan 1, 1986·Clinical Pharmacology and Therapeutics·P G WilcoxS G Carruthers
May 1, 1985·Clinical Pharmacology and Therapeutics·N M WoolhouseR L Smith
Oct 1, 1985·Clinical Pharmacology and Therapeutics·E SteinerF Sjöqvist
Sep 26, 1970·British Medical Journal·D J Coltart, D G Shand
Sep 1, 1971·British Journal of Pharmacology·J D Fitzgerald, S R O'Donnell
Mar 1, 1972·Clinical Pharmacology and Therapeutics·C R Cleaveland, D G Shand
Sep 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·T H Morris, A J Kaumann
May 1, 1982·British Journal of Clinical Pharmacology·P DayerJ Fabre
Aug 1, 1982·British Journal of Clinical Pharmacology·M S LennardJ Trevethick
Jan 1, 1982·European Journal of Clinical Pharmacology·R J FrancisJ Larman
Jan 1, 1983·Pharmacology & Therapeutics·M J Kendall, L Beeley
Jul 28, 1984·Lancet·R G Cooper, D A Evans
Jun 1, 1984·European Journal of Clinical Investigation·E I MinderU A Meyer

❮ Previous
Next ❯

Citations

Oct 1, 1992·Journal of Clinical Pharmacology·C A NaranjoK L Lanctôt
Apr 10, 1993·Lancet·T WalleyD Maxwell
Jan 1, 1990·Pharmacology & Therapeutics·M Eichelbaum, A S Gross
Dec 1, 1992·Trends in Pharmacological Sciences·S CholertonJ R Idle
Apr 13, 2000·Pharmacology & Therapeutics·K Nakagawa, T Ishizaki
Oct 27, 1997·Journal of Pharmacological and Toxicological Methods·P D ColbourneR T Coutts
Oct 1, 1990·Pharmacology & Toxicology·M S Lennard
Nov 8, 2007·The Annals of Pharmacotherapy·Milo Gibaldi
Jul 1, 1995·Biopharmaceutics & Drug Disposition·B TrauschT Gramatté
Nov 14, 1997·Clinical Pharmacology and Therapeutics·M WadeliusA Rane
Jan 1, 1992·The Annals of Pharmacotherapy·M Gibaldi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.